Chemed Corporation

CHE Healthcare Medical Care Facilities

Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024. In the quarter to June 2026, revenue grew 8.80%, EPS grew 42.8% and free cash flow fell 43.5%, each against the same quarter a year earlier. Dividend growth for twenty-five consecutive years, revenue growth for three.

512.38 3.06 −0.59%
Market cap
$6.7B
P/E
25.7×
Fwd P/E
20.4×
Dividend yield
0.49%
F-score
6/9
Altman Z
11.69
Beneish M
−2.76
Dividend safety
100/100

Chemed Corporation (CHE) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Chemed Corporation (CHE) trades at a P/E ratio of 25.7×. Over the past ten years it has ranged from 17.5× (January 2015) to 52.7× (December 2017); the current reading is higher than 40% of that period. That is above the Medical Care Facilities industry median of 20.6× and above the Healthcare sector median of 23.0×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 23.2× (11.93%)
FY2024 26.3× (18.51%)
FY2023 32.3× 6.59%
FY2022 30.3× (1.66%)
FY2021 30.8× 15.94%
FY2020 26.6× (16.70%)
FY2019 31.9× 44.24%
FY2018 22.1× (45.25%)
FY2017 40.4× 65.82%
FY2016 24.4× 6.43%

Quarterly newest first

Period P/E ratio Change
Jun 2026 23.4× 13.77%
Mar 2026 20.5× (11.43%)
Dec 2025 23.2× (1.33%)
Sep 2025 23.5× (5.25%)
42 more quarters

Against its own ten years

Low 17.5× High 52.7×
Ten-year median 27.1×
Current reading's percentile 35

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on CHE